Literature DB >> 28455823

[Impact of conflicts of interest on guideline recommendations : Empirical study within the second update of the German interdisciplinary S3 guidelines on fibromyalgia syndrome].

W Häuser1,2, F Petzke3, I Kopp4, M Nothacker4.   

Abstract

BACKGROUND: The impact of conflicts of interest (COI) in general and of academic COI in particular on guideline recommendations in pain medicine has not yet been studied. Whether the inclusion of patients and of representatives of all relevant healthcare professions into a guidelines group is protective against a systematic bias of decisions of a guidelines group is currently unknown.
METHODS: All members of the guidelines group declared their COI before the consensus conferences by a standard form according to the rules and standards of the Association of the German Medical and Scientific Societies. The acceptance or rejection and the strength of consensus of recommendations of the second update of the interdisciplinary guidelines on fibromyalgia syndrome was analyzed twice by first including and then excluding the votes of the guideline group members with COI related to a recommendation from the results of anonymous voting via an internet platform.
RESULTS: A total of 42 persons from different healthcare professions and patients participated in the online voting on recommendations. Of the participants 29% had no COI according to the predefined criteria, 53% met the criteria of academic and 33% the criteria of financial COI. In the case of exclusion of participants with a COI related to a specific recommendation, 2 out of 23 recommendations (homeopathy, tramadol) were not accepted. In all votes, there were more participants without COI than with COI.
CONCLUSION: Academic COI were more frequent than financial COI in the second update of the German interdisciplinary guidelines group on fibromyalgia syndrome. The impact of COI on guideline recommendations was low. The inclusion of patients and of all relevant healthcare professionals into a guidelines group is a protective factor against the influence of COI on guideline recommendations.

Entities:  

Keywords:  Conflict of interest; Fibromyalgia syndrome; Guidelines

Mesh:

Year:  2017        PMID: 28455823     DOI: 10.1007/s00482-017-0218-x

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  12 in total

1.  [Methodological fundamentals of the development of the guideline].

Authors:  W Häuser; K Bernardy; H Wang; I Kopp
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  Guidelines International Network: Principles for Disclosure of Interests and Management of Conflicts in Guidelines.

Authors:  Holger J Schünemann; Lubna A Al-Ansary; Frode Forland; Sonja Kersten; Jorma Komulainen; Ina B Kopp; Fergus Macbeth; Susan M Phillips; Craig Robbins; Philip van der Wees; Amir Qaseem
Journal:  Ann Intern Med       Date:  2015-10-06       Impact factor: 25.391

3.  The Hidden Costs of Financial Conflicts of Interest in Medicine.

Authors:  Giovanni A Fava
Journal:  Psychother Psychosom       Date:  2016-01-26       Impact factor: 17.659

4.  Developing unbiased diagnostic and treatment guidelines in psychiatry.

Authors:  Lisa Cosgrove; Harold J Bursztajn; Sheldon Krimsky
Journal:  N Engl J Med       Date:  2009-05-07       Impact factor: 91.245

Review 5.  Fibromyalgia wars.

Authors:  Frederick Wolfe
Journal:  J Rheumatol       Date:  2009-04       Impact factor: 4.666

6.  Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.

Authors:  Lisa Cosgrove; Sheldon Krimsky; Emily E Wheeler; Shannon M Peters; Madeline Brodt; Allen F Shaughnessy
Journal:  Account Res       Date:  2016-10-24       Impact factor: 2.622

Review 7.  Fibromyalgia.

Authors:  Winfried Häuser; Jacob Ablin; Mary-Ann Fitzcharles; Geoffrey Littlejohn; Juan V Luciano; Chie Usui; Brian Walitt
Journal:  Nat Rev Dis Primers       Date:  2015-08-13       Impact factor: 52.329

8.  Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study.

Authors:  Jennifer Neuman; Deborah Korenstein; Joseph S Ross; Salomeh Keyhani
Journal:  BMJ       Date:  2011-10-11

9.  Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.

Authors:  Julie Bolette Brix Bindslev; Jeppe Schroll; Peter C Gøtzsche; Andreas Lundh
Journal:  BMC Med Ethics       Date:  2013-05-03       Impact factor: 2.652

10.  Management of fibromyalgia syndrome--an interdisciplinary evidence-based guideline.

Authors:  Winfried Häuser; Bernhard Arnold; Wolfgang Eich; Eva Felde; Christl Flügge; Peter Henningsen; Markus Herrmann; Volker Köllner; Edeltraud Kühn; Detlev Nutzinger; Martin Offenbächer; Marcus Schiltenwolf; Claudia Sommer; Kati Thieme; Ina Kopp
Journal:  Ger Med Sci       Date:  2008-12-09
View more
  2 in total

Review 1.  Financial Conflicts of Interest in Clinical Practice Guidelines: A Systematic Review.

Authors:  Sahar Tabatabavakili; Rishad Khan; Michael A Scaffidi; Nikko Gimpaya; David Lightfoot; Samir C Grover
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-01-19

Review 2.  Patient and public involvement in the development of clinical practice guidelines: a scoping review.

Authors:  Elizabeth Ann Bryant; Anna Mae Scott; Hannah Greenwood; Rae Thomas
Journal:  BMJ Open       Date:  2022-09-28       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.